Clinical Trials Browser

Klatskin Tumor × lenvatinib × Clear all

NCT04211168 2023-03-29

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Phase 2 Unknown

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor